Co-Authors
This is a "connection" page, showing publications co-authored by Jose Scher and Rebecca Haberman.
Connection Strength
4.206
-
Editorial: Rheumatology at the center of coronavirus disease 2019: pathogenesis, treatment, and clinical care. Curr Opin Rheumatol. 2021 09 01; 33(5):409-411.
Score: 0.965
-
Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease. Ann Rheum Dis. 2021 10; 80(10):1339-1344.
Score: 0.947
-
More on Covid-19 in Immune-Mediated Inflammatory Diseases. Reply. N Engl J Med. 2020 08 20; 383(8):797-798.
Score: 0.892
-
Covid-19 in Immune-Mediated Inflammatory Diseases - Case Series from New York. N Engl J Med. 2020 07 02; 383(1):85-88.
Score: 0.879
-
COVID-19 in Patients With Inflammatory Arthritis: A Prospective Study on the Effects of Comorbidities and Disease-Modifying Antirheumatic Drugs on Clinical Outcomes. Arthritis Rheumatol. 2020 12; 72(12):1981-1989.
Score: 0.227
-
Evaluation of Immune Response and Disease Status in Systemic Lupus Erythematosus Patients Following SARS-CoV-2 Vaccination. Arthritis Rheumatol. 2022 02; 74(2):284-294.
Score: 0.062
-
Psoriasis and Psoriatic Arthritis in the Context of the COVID-19 Pandemic: A Plenary Session From the GRAPPA 2020 Annual Meeting. J Rheumatol Suppl. 2021 Jun; 97:24-29.
Score: 0.059
-
Evaluation of SARS-CoV-2 IgG antibody reactivity in patients with systemic lupus erythematosus: analysis of a multi-racial and multi-ethnic cohort. Lancet Rheumatol. 2021 Aug; 3(8):e585-e594.
Score: 0.059
-
Psoriasis and Psoriatic Arthritis in the Context of the COVID-19 Pandemic: A Plenary Session From the GRAPPA 2020 Annual Meeting. J Rheumatol. 2021 Mar 15.
Score: 0.058
-
Leveraging the United States Epicenter to Provide Insights on COVID-19 in Patients With Systemic Lupus Erythematosus. Arthritis Rheumatol. 2020 12; 72(12):1971-1980.
Score: 0.057